Hinge Health revenue jumps 52% in Q3 as it expands beyond MSK, eyes hardware acquisitionsNovember 3, 2026
New study identifies biological mechanism driving therapy resistance in advanced prostate cancerNovember 3, 2026
General Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPABy Healthcare Propulsion StaffOctober 26, 20260 Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver…
